Fortification of yogurts with vitamin D and calcium enhances the inhibition of serum parathyroid hormone and bone resorption markers: A double blind randomized controlled trial in women over 60 living in a community dwelling home

Journal of Nutrition, Health and Aging

Volumn 19, Issue 5, 2015, Pages 563-569

  Bonjour, Jean Philippe ^a   Benoit, V ^b   Atkin, S ^c   Walrand, S ^d  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Yoplait   (France)

^c Centre for Diabetes and Endocrinology   (United Kingdom)

^d INRA and University of Auvergne   (France)

Author keywords

bone resorption; calcium vitamin D fortified yogurts; nutritional intervention; Osteoporosis prevention; secondary hyperparathyroidism

Indexed keywords

ACID PHOSPHATASE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; BIOLOGICAL MARKER; CALCIUM INTAKE; COLECALCIFEROL; COLLAGEN TYPE 1; ISOENZYME; PARATHYROID HORMONE; YOGHURT;

ADMINISTRATION AND DOSAGE; AGED; BLOOD; CALCIUM INTAKE; CAUCASIAN; CONTROLLED STUDY; DIET THERAPY; DOUBLE BLIND PROCEDURE; FEMALE; FORTIFIED FOOD; HIP FRACTURES; HUMAN; HYPERPARATHYROIDISM, SECONDARY; MIDDLE AGED; NURSING HOME; OSTEOLYSIS; OSTEOPOROTIC FRACTURES; PHARMACOLOGY; PREVENTION AND CONTROL; RANDOMIZED CONTROLLED TRIAL; RISK; THERAPEUTIC USE; VERY ELDERLY;

ACID PHOSPHATASE; AGED; AGED, 80 AND OVER; BIOMARKERS; BONE RESORPTION; CALCIUM, DIETARY; CHOLECALCIFEROL; COLLAGEN TYPE I; DOUBLE-BLIND METHOD; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOOD, FORTIFIED; HIP FRACTURES; HUMANS; HYPERPARATHYROIDISM, SECONDARY; ISOENZYMES; MIDDLE AGED; NURSING HOMES; OSTEOPOROTIC FRACTURES; PARATHYROID HORMONE; RISK; TARTRATE-RESISTANT ACID PHOSPHATASE; YOGURT;

EID: 84939970086     PISSN: 12797707     EISSN: 17604788     Source Type: Journal    
DOI: 10.1007/s12603-015-0498-8     Document Type: Article

References (41)

1. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001;22(4):477–501.
2. Naylor K, Eastell R. Bone turnover markers: use in osteoporosis. NatRevRheumatol. 2012;8(7):379–389.
3. Bonjour JP, Benoit V, Payen F, Kraenzlin M. Consumption of yogurts fortified in vitamin d and calcium reduces serum parathyroid hormone and markers of bone resorption: a double-blind randomized controlled trial in institutionalized elderly women. J Clin Endocrinol Metab. 2013;98(7):2915–2921.
4. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med. 1992;327(23):1637–1642.
5. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 1997;337(10):670–676.
6. Boonen S, Lips P, Bouillon R, Bischoff-Ferrari HA, Vanderschueren D, Haentjens P. Need for additional calcium to reduce the risk of hip fracture with vitamin d supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab. 2007;92(4):1415–1423.
7. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, Wong JB. Effect of Vitamin D on falls: a meta-analysis. Jama. 2004;291(16):1999–2006.
8. Greenspan SL, Resnick NM, Parker RA. Early changes in biochemical markers of bone turnover are associated with long-term changes in bone mineral density in elderly women on alendronate, hormone replacement therapy, or combination therapy: a three-year, double-blind, placebo-controlled, randomized clinical trial. J Clin Endocrinol Metab. 2005;90(5):2762–2767.
9. Johnell O, Oden A, De Laet C, Garnero P, Delmas PD, Kanis JA. Biochemical indices of bone turnover and the assessment of fracture probability. Osteoporos Int. 2002;13(7):523–526.
10. Bonjour JP, Kohrt W, Levasseur R, Warren M, Whiting S, Kraenzlin M. Biochemical markers for assessment of calcium economy and bone metabolism: application in clinical trials from pharmaceutical agents to nutritional products. Nutr Res Rev. 2014:27:252–267.
11. Heaney RP. Design Considerations for Clinical Investigations of Osteoporosis. In: Marcus M, Feldman D, Nelson DA, Rosen CJ, editors. Osteoporosis. 3rd Edition ed. Amsterdam: Elsevier, Inc; 2008. p. 1598–1620.
12. Kaats GR, Preuss HG, Leckie RB. Comparative Effectiveness Research (CER): Opportunities and Challenges for the Nutritional Industry. J Am Coll Nutr. 2009;28(3):234–237.
13. Michalek JE, Preuss HG, Croft HA, Keith PL, Keith SC, Dapilmoto M, Perricone NV, Leckie RB, Kaats GR. Changes in total body bone mineral density following a common bone health plan with two versions of a unique bone health supplement: a comparative effectiveness research study. Nutr J. 2011;10–32.
14. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. JClinEndocrinolMetab. 2011;96(1):53–58.
15. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–1930.
16. Kanis JA, Oden A, Johansson H, Borgstrom F, Strom O, McCloskey E. FRAX and its applications to clinical practice. Bone. 2009;44(5):734–743.
17. Kanis JA, McCloskey E, Johansson H, Oden A, Leslie WD. FRAX((R)) with and without bone mineral density. Calcif Tissue Int. 2012;90(1):1–13.
18. Thompson FE, Byers T. Dietary assessment resource manual. J Nutr. 1994;124(11 Suppl):2245S–2317S.
19. Bonjour JP, Benoit V, Rousseau B, Souberbielle JC. Consumption of Vitamin D-and Calcium-Fortified Soft White Cheese Lowers the Biochemical Marker of Bone Resorption TRAP 5b in Postmenopausal Women at Moderate Risk of Osteoporosis Fracture. J Nutr. 2012;142(4):698–703.
20. Dawson B, Trapp RG. Basic and Clinical Biostatistics. 3rd ed. New York: Lange Medical Books/McGraw-Hill; 2001.
21. Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, Nicholson GC. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. 2010;303(18):1815–1822.
22. Bolland MJ, Grey A, Gamble GD, Reid IR. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol. 2014;2(4):307–320.
23. Avenell A, Mak JC, O’Connell D. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev. 2014;4:CD0002–7.
24. Dawson-Hughes B, Harris SS. High-dose vitamin D supplementation: too much of a good thing? JAMA. 2010;303(18):1861–1862.
25. Grant WB. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes. Lancet Diabetes Endocrinol. 2014;2(5):3–4.
26. Ng K, Hollis BW, Giovannucci EL, Fuchs CS. Reply to PM Brannon et al. Am J Clin Nutr. 2014;100(3):984–986.
27. Mak JC. High-dose oral vitamin D supplementation and risk of falls in older women. JAMA. 2010;304(8):854; author reply 856–857.
28. Bischoff-Ferrari HA, Orav EJ, Willett WC, Dawson-Hughes B. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes. Lancet Diabetes Endocrinol. 2014;2(5):363–364.
29. Davies JS, Poole CD. Vitamin D and falls. Lancet Diabetes Endocrinol. 2014;2(7):540–541.
30. Ng K, Scott JB, Drake BF, Chan AT, Hollis BW, Chandler PD, Bennett GG, Giovannucci EL, Gonzalez-Suarez E, Meyerhardt JA, et al. Dose response to vitamin D supplementation in African Americans: results of a 4-arm, randomized, placebocontrolled trial. Am J Clin Nutr. 2014;99(3):587–598.
31. Taylor CL, Carriquiry AL, Bailey RL, Sempos CT, Yetley EA. Appropriateness of the probability approach with a nutrient status biomarker to assess population inadequacy: a study using vitamin D. Am J Clin Nutr. 2013;97(1):72–78.
32. Brannon PM, Mayne ST, Murphy SP, Taylor CL. Vitamin D supplementation in African Americans: dose-response. Am J Clin Nutr. 2014;100(3):982–984.
33. Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, Burckhardt P, Fuleihan GE, Josse RG, Lips P, Morales-Torres J, Yoshimura N. IOF position statement: vitamin D recommendations for older adults. Osteoporos Int. 2010;21(7):1151–1154.
34. Annweiler C, Montero-Odasso M, Llewellyn DJ, Richard-Devantoy S, Duque G, Beauchet O. Meta-analysis of memory and executive dysfunctions in relation to vitamin D. J Alzheimers Dis. 2013;37(1):147–171.
35. Bartali B, Devore E, Grodstein F, Kang JH. Plasma vitamin D levels and cognitive function in aging women: the nurses’ health study. J Nutr Health Aging. 2014;18(4):400–406.
36. Latimer CS, Brewer LD, Searcy JL, Chen KC, Popovic J, Kraner SD, Thibault O, Blalock EM, Landfield PW, Porter NM. Vitamin D prevents cognitive decline and enhances hippocampal synaptic function in aging rats. Proc Natl Acad Sci U S A. 2014;111(41):E4359–4366.
37. Marcelli C, Chavoix C, Dargent-Molina P. Beneficial effects of vitamin D on falls and fractures: is cognition rather than bone or muscle behind these benefits? Osteoporos Int. 2014.
38. Rolland Y, de Souto Barreto P, Abellan Van Kan G, Annweiler C, Beauchet O, Bischoff-Ferrari H, Berrut G, Blain H, Bonnefoy M, Cesari M, et al. Vitamin D supplementation in older adults: searching for specific guidelines in nursing homes. J Nutr Health Aging. 2013;17(4):402–412.
39. Barger-Lux MJ, Heaney RP, Dowell S, Chen TC, Holick MF. Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int. 1998;8(3):222–230.
40. Lips P, Duong T, Oleksik A, Black D, Cummings S, Cox D, Nickelsen T. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab. 2001;86(3):1212–1221.
41. van Ballegooijen AJ, Reinders I, Visser M, Brouwer IA. Parathyroid hormone and cardiovascular disease events: A systematic review and meta-analysis of prospective studies. Am Heart J. 2013;165(5):655–664, 664 e651–655.